Friday, September 24, 2010

New Oral Medication for MS

The U.S. Food and Drug Administration has approved fingolimod capsules (Gilenya,™ Novartis International AG) for reducing the frequency of clinical relapses and delaying the accumulation of physical disability in relapsing forms of MS, making it the first oral disease-modifying therapy for the treatment of multiple sclerosis. According to Novartis, the drug will be available for prescription in coming weeks.

If you would like to read the entire article go here.

Maybe someday soon Avonex shots will be a distant memory for me!!!

1 comment:

  1. One of those two post-production platinum models did rolex replica sale eventually leave Patek, at the historic "The Art of Patek Philippe" auction in 1989, and was sold privately until it ended up replica watches uk with rock legend and serious watch collector Eric Clapton. It was, and will certainly remain, the only white-metal 2499 in private hands. Since it left Patek, it was available to the public for the first time when it was sold by rolex replica sale Christie's in 2012. The final bid for the 2499/100P exceeded 3.6 million US dollars. Although Patek has stopped producing their Reference 5004, for the 5th Only Watch auction (held in September, 2013) they went on to create replica watches one final and completely unique version, the 5004T. It is housed in a highly polished rolex replica uk titanium case, a seldom-used material by Patek. Making the design even more distinct compared to other 5004 versions (and other Patek watches in general) is a dial made of solid replica watches uk gold, hand-engraved with a checkered pattern.

    ReplyDelete